Continue to site >
Trending ETFs

Virtus LifeSci Biotech Products ETF

ETF
BBP
Dividend policy
Suspended
Price as of:
$ N/A 0
primary theme
Health Care Sector Equity
BBP (ETF)

Virtus LifeSci Biotech Products ETF

Dividend policy
Suspended
Price as of:
$ N/A 0
primary theme
Health Care Sector Equity
BBP (ETF)

Virtus LifeSci Biotech Products ETF

Dividend policy
Suspended
Price as of:
$ N/A 0
primary theme
Health Care Sector Equity

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

-

-

0.00%

$0.00

0.79%

Vitals

YTD Return

-2.0%

1 yr return

11.9%

3 Yr Avg Return

4.9%

5 Yr Avg Return

11.7%

Net Assets

$26.3 M

Holdings in Top 10

25.8%

52 WEEK LOW AND HIGH

N/A
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 0.79%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 46.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

-

-

0.00%

$0.00

0.79%

BBP - Profile

Distributions

  • YTD Total Return -2.0%
  • 3 Yr Annualized Total Return 4.9%
  • 5 Yr Annualized Total Return 11.7%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.43%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Virtus LifeSci Biotech Products ETF
  • Fund Family Name
    Virtus
  • Inception Date
    Dec 16, 2014
  • Shares Outstanding
    500004
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Matthew Brown

Fund Description

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.


BBP - Performance

Return Ranking - Trailing

Period BBP Return Category Return Low Category Return High Rank in Category (%)
YTD -2.0% -79.8% 39.4% 89.25%
1 Yr 11.9% -28.4% 92.6% 91.41%
3 Yr 4.9%* -0.3% 38.2% 97.30%
5 Yr 11.7%* 2.2% 38.6% 86.62%
10 Yr N/A* 9.4% 21.6% N/A

* Annualized

Return Ranking - Calendar

Period BBP Return Category Return Low Category Return High Rank in Category (%)
2020 22.2% -13.6% 178.2% 19.08%
2019 24.7% 3.8% 63.8% 24.83%
2018 -14.0% -49.7% 21.5% 82.48%
2017 23.8% -59.8% 54.4% 26.67%
2016 6.3% -36.6% 11.6% 3.13%

Total Return Ranking - Trailing

Period BBP Return Category Return Low Category Return High Rank in Category (%)
YTD -2.0% -79.8% 39.4% 89.25%
1 Yr 11.9% -30.4% 92.6% 89.59%
3 Yr 4.9%* -15.9% 38.2% 95.53%
5 Yr 11.7%* -7.4% 38.6% 76.88%
10 Yr N/A* 9.4% 21.6% N/A

* Annualized

Total Return Ranking - Calendar

Period BBP Return Category Return Low Category Return High Rank in Category (%)
2020 22.2% -13.6% 178.2% 19.08%
2019 24.7% 3.8% 63.8% 24.83%
2018 -14.0% -25.3% 22.2% 83.94%
2017 23.8% -10.8% 54.4% 30.37%
2016 6.3% -36.6% 11.6% 3.91%

BBP - Holdings

Concentration Analysis

BBP Category Low Category High BBP % Rank
Net Assets 26.3 M 2.72 M 53.2 B 88.07%
Number of Holdings 54 11 478 64.83%
Net Assets in Top 10 6.79 M 2.18 K 21.1 B 67.37%
Weighting of Top 10 25.77% 10.1% 94.7% 91.95%

Top 10 Holdings

  1. Immunomedics Inc 5.61%
  2. Amicus Therapeutics Inc 4.68%
  3. Aimmune Therapeutics Inc 3.93%
  4. Ultragenyx Pharmaceutical Inc 3.89%
  5. Agios Pharmaceuticals Inc 3.58%
  6. Moderna Inc 3.52%
  7. Momenta Pharmaceuticals Inc 3.45%
  8. BeiGene Ltd ADR 3.44%
  9. Intra-Cellular Therapies Inc 3.42%
  10. Insmed Inc 3.21%

Asset Allocation

Weighting Return Low Return High BBP % Rank
Stocks
97.97% 83.68% 101.79% 78.39%
Cash
2.03% -0.65% 10.70% 14.41%
Preferred Stocks
0.00% 0.00% 5.96% 23.31%
Other
0.00% -24.25% 9.11% 31.78%
Convertible Bonds
0.00% 0.00% 0.06% 16.95%
Bonds
0.00% 0.00% 15.36% 21.19%

Stock Sector Breakdown

Weighting Return Low Return High BBP % Rank
Healthcare
100.00% 61.99% 100.00% 5.51%
Utilities
0.00% 0.00% 0.98% 16.95%
Technology
0.00% 0.00% 19.13% 24.58%
Real Estate
0.00% 0.00% 6.13% 20.76%
Industrials
0.00% 0.00% 7.02% 23.31%
Financial Services
0.00% 0.00% 1.92% 39.83%
Energy
0.00% 0.00% 0.71% 16.95%
Communication Services
0.00% 0.00% 7.81% 19.49%
Consumer Defense
0.00% 0.00% 28.21% 23.31%
Consumer Cyclical
0.00% 0.00% 17.63% 22.88%
Basic Materials
0.00% 0.00% 8.23% 39.83%

Stock Geographic Breakdown

Weighting Return Low Return High BBP % Rank
US
91.55% 57.23% 100.70% 25.42%
Non US
6.42% 0.00% 42.77% 78.39%

BBP - Expenses

Operational Fees

BBP Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.79% 0.08% 2.91% 43.10%
Management Fee 0.79% 0.00% 1.25% 68.36%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

BBP Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BBP Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BBP Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 46.00% 0.00% 256.00% 53.89%

BBP - Distributions

Dividend Yield Analysis

BBP Category Low Category High BBP % Rank
Dividend Yield 0.00% 0.00% 2.44% 31.78%

Dividend Distribution Analysis

BBP Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Semi-Annually

Net Income Ratio Analysis

BBP Category Low Category High BBP % Rank
Net Income Ratio -0.43% -2.54% 1.92% 76.88%

Capital Gain Distribution Analysis

BBP Category Low Category High Capital Mode
Capital Gain Distribution Frequency

Dividend Payout History

View More +

BBP - Fund Manager Analysis

Managers

Matthew Brown


Start Date

Tenure

Tenure Rank

Aug 14, 2017

4.05

4.1%

Matthew Brown serves as Portfolio Manager at Virtus ETF Advisers LL. Mr. Brown is also executive managing director and chief operating officer at Virtus ETF Solutions LLC (“VES”) since 2012. Before founding VES in 2012, he served as director of operations for Factor Advisors from 2010 to 2012. In 2009, Mr. Brown co-founded ETP Resources, a consulting and data services business that continues to grow and serve the ETF industry. From 2008 to 2009, he headed U.S. operations and served as chief compliance officer for U.K.-based issuer SPA/London & Capital. Mr. Brown earned a B.A. in Economics from Boston College.

Seth Kadushin


Start Date

Tenure

Tenure Rank

Aug 14, 2017

4.05

4.1%

Seth Kadushin serves as Portfolio Manager at Virtus ETF Advisers LLC. Mr. Kadushin has also served as director of capital markets at Virtus ETF Solutions LLC (“VES”) since 2013. Prior to joining VES, Mr. Kadushin worked at Euromoney Institutional Investor, Plc where he developed large scale investment management programs focusing on Exchange Traded Instruments and Alternate Investment Strategies. From 2011 through 2012 Mr. Kadushin worked at Wedbush Securities as an Options Desk Strategist. Mr. Kadushin worked at RBS Securities as Head Program Trader from 2009 through 2011. Prior to 2009, Mr. Kadushin held senior level positions at Lehman Brothers and Bear Sterns (J.P. Morgan), where he was a member of the firm’s Cross Asset Policy Committee charged with instituting their equity trading division’s guidelines. Mr. Kadushin holds a BBA in Finance from Emory University. He achieved his Master’s in Business from Fordham University with a concentration in Information Systems.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 23.98 6.66 1.38